NeueHealth, Inc.

NYSE:NEUE Stock Report

Market Cap: US$31.5m

NeueHealth Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSE:NEUE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Mar 24SellUS$36,277George MikanIndividual4,990US$7.27
18 Mar 24SellUS$7,873Jay MatushakIndividual1,083US$7.27
18 Mar 24SellUS$1,890Jeff CraigIndividual260US$7.27
18 Mar 24SellUS$5,976Tomas OrozcoIndividual822US$7.27
18 Mar 24SellUS$4,129Jeffrey SchermanIndividual568US$7.27
15 Mar 24SellUS$41,368George MikanIndividual5,840US$7.10
15 Mar 24SellUS$2,982Jay MatushakIndividual421US$7.10
15 Mar 24SellUS$1,813Jeff CraigIndividual256US$7.10
15 Mar 24SellUS$942Tomas OrozcoIndividual133US$7.10
15 Mar 24SellUS$1,176Jeffrey SchermanIndividual166US$7.10
13 Mar 24SellUS$59,285George MikanIndividual7,725US$8.11
13 Mar 24SellUS$4,298Jay MatushakIndividual560US$8.11
13 Mar 24SellUS$1,335Tomas OrozcoIndividual174US$8.11
13 Mar 24SellUS$2,602Jeff CraigIndividual339US$8.11
13 Mar 24SellUS$1,688Jeffrey SchermanIndividual220US$8.11
08 Mar 24SellUS$46,080George MikanIndividual5,417US$9.88

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NEUE?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders634,5897.69%
Institutions1,032,14712.5%
General Public2,333,04128.3%
VC/PE Firms4,253,48551.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.8%.

Top Shareholders

Top 25 shareholders own 71.05% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
33%
New Enterprise Associates, Inc.
2,726,917US$10.4m0%0.55%
12.1%
Deer Management Company, LLC
999,218US$3.8m0%0.14%
6.39%
StepStone Group Inc.
527,350US$2.0m0.4%0.61%
3.1%
Robert Sheehy
255,445US$975.8k0%no data
2.29%
Redpoint Management, LLC
189,348US$723.3k0%0.09%
2.03%
The Vanguard Group, Inc.
167,777US$640.9k0%no data
1.68%
Greycroft LP
138,352US$528.5k0%0.47%
1.21%
Linda Gooden
99,864US$381.5k0%no data
1.21%
Kedrick Adkins
99,864US$381.5k0%no data
1.07%
Partners Group Holding AG
88,645US$338.6k18.4%0.01%
1.01%
Town Hall Ventures
83,656US$319.6k0%no data
1.01%
George Mikan
83,029US$317.2k28.1%no data
0.99%
BlackRock, Inc.
81,959US$313.1k4.21%no data
0.7%
Renaissance Technologies LLC
57,763US$220.7k0.7%no data
0.64%
HarbourVest Partners, LLC
52,720US$201.4k0%0.09%
0.56%
Blackstone Inc.
45,916US$175.4k0%no data
0.41%
Geode Capital Management, LLC
33,447US$127.8k2.99%no data
0.36%
Legacy Wealth Asset Management, LLC
29,906US$114.2k0%0.03%
0.28%
Manuel Kadre
23,006US$87.9k0%no data
0.24%
Northern Trust Global Investments
19,570US$74.8k-2.98%no data
0.17%
Andrew Slavitt
13,654US$52.2k0%no data
0.16%
Jeffrey Immelt
13,419US$51.3k0%no data
0.15%
State Street Global Advisors, Inc.
12,381US$47.3k0%no data
0.14%
Pathway Capital Management, LP
11,201US$42.8k0%0.05%
0.11%
Jay Matushak
9,480US$36.2k1.89%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 10:00
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NeueHealth, Inc. is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steven ValiquetteBarclays
Steven ValiquetteBarclays
Kevin FischbeckBofA Global Research